Condition

Alzheimer's Disease (1)

Child Development (1)

Depression (1)

Healthy (1)

Healthy Volunteer (1)

Healthy Volunteers (1)

Heart Failure (1)

Mild Cognitive Impairment Due to Alzheimer's Disease (1)

Self-regulation (1)

Overall Status

Terminated (2)

Active, not recruiting (1)

Recruiting (1)

Phase

phase 1 (2)

n/a (1)

phase 3 (1)

Sponsor

APRINOIA Therapeutics (1)

Amgen (1)

Tasly Pharmaceuticals, Inc. (1)

University of Manitoba (1)

Collaborator

Centre for Addiction and Mental Health (1)

Research Manitoba (1)

University of Oregon (1)

Intervention

[18f]apn-1607 (1)

amg 986 iv (1)

amg 986 po (1)

bridge therapy program (1)

jiashen tablets (1)

jiashen tablets placebo (1)

placebo iv (1)

placebo po (1)

Study Documents

Intervention Type

drug (3)

behavioral (1)

Funder Type

Industry (3)

Other (1)

Study Type

Interventional (4)

MDAD

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Alzheimer's Disease, Mild Cognitive Impairment Due to Alzheimer's Disease, Healthy Volunteers Trial in Wuhan ([18F]APN-1607)

Recruiting

Alzheimer's Disease
+2 more

[18F]APN-1607

Wuhan, Hubei, China

Union Hospital Tongji Medical College Huazhong University of Sci

Sep 13, 2022

Heart Failure, Healthy Volunteer Trial in Worldwide (AMG 986 IV, AMG 986 PO, Placebo PO)

Terminated

Has Results

Heart Failure
Healthy Volunteer

AMG 986 IV
+3 more

Anaheim, California
+24 more

Mar 30, 2022

Healthy Trial in Tianjin (Jiashen Tablets, Jiashen Tablets Placebo)

Active, not recruiting

Healthy

Jiashen Tablets
Jiashen Tablets Placebo

Tianjin, Tianjin, China

The second affiliated hospital of tianjin university of traditio

Apr 1, 2021

Depression, Self-regulation, Child Development Trial in Winnipeg (BRIDGE Therapy Program)

Terminated

Depression
+2 more

BRIDGE Therapy Program

Winnipeg, Manitoba, Canada

University of Manitoba

Nov 16, 2020